2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one
- $45 - $2378
- Product name: 2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one
- CAS: 155778-36-2
- MF: C7H9N3OS
- MW: 183.23
- EINECS:
- MDL Number:MFCD00460522
- Synonyms:2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one;2-amino-4H,5H,6H,7H,8H-[1,3]thiazolo[5,4-c]azepin-4-one;2-Amino-5,6,7,8-tetrahydro-thiazolo[5,4-c]azepin-4-one;4H-Thiazolo[5,4-c]azepin-4-one, 2-amino-5,6,7,8-tetrahydro-
3 prices
Selected condition:
Brand
- AK Scientific
- TRC
Package
- 10mg
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number8508BA
- Product description2-Amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one
- Packaging500mg
- Price$710
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8508BA
- Product description2-Amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one
- Packaging5g
- Price$2378
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA638218
- Product description2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8508BA | 2-Amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one | 500mg | $710 | 2021-12-16 | Buy |
AK Scientific | 8508BA | 2-Amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one | 5g | $2378 | 2021-12-16 | Buy |
TRC | A638218 | 2-amino-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-4-one | 10mg | $45 | 2021-12-16 | Buy |
Properties
Boiling point :540.6±29.0 °C(Predicted)
Density :1.393±0.06 g/cm3(Predicted)
pka :13.91±0.20(Predicted)
Density :1.393±0.06 g/cm3(Predicted)
pka :13.91±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|